GoodRx Holdings, Inc. GDRX Amortization expense related to capitalized debt issuance costs
Amortization expense related to capitalized debt issuance costs at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s amortization expense related to capitalized debt issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s amortization expense related to capitalized debt issuance costs?
- GoodRx Holdings, Inc. (GDRX) reported amortization expense related to capitalized debt issuance costs of $462K in Q1 2026.
- How has GoodRx Holdings, Inc.'s amortization expense related to capitalized debt issuance costs changed year-over-year?
- GoodRx Holdings, Inc.'s amortization expense related to capitalized debt issuance costs increased by 7.4% year-over-year, from $430K to $462K.
- What is the long-term trend for GoodRx Holdings, Inc.'s amortization expense related to capitalized debt issuance costs?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s amortization expense related to capitalized debt issuance costs has grown at a -15.4% compound annual growth rate (CAGR), from $3.45M to $1.77M.